Horizon Pharma | HZNP - Денежные средства и эквиваленты



Денежные средства и эквиваленты Изменить Дата
AbbVie USD 5.23B 400M 2025-12
ALKERMES USD 351.55M 37.02M 2026-03
Amgen USD 12.04B 2.91B 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bausch Health Companies USD 1.31B 1000K 2025-12
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Cara Therapeutics USD 21.42M 770K 2025-09
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
Merck USD 5.33B 9.24B 2026-03
Novartis USD 6.88B 4.56B 2026-03
Pacira USD 144.31M 14.24M 2026-03
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.7B 561M 2026-03
Prestige Brands USD 62.37M 56.73M 2025-12
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Takeda JPY 654.94B 26.55B 2025-12
Xeris Pharmaceuticals USD 111.04M 19.44M 2025-12
Zoetis USD 2.08B 649M 2025-09